Archives pour la catégorie Article du mois

Article du mois de novembre

Prospective and clinical validation of ALK immunohistochemistry: Results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)

K. TakeuchiTakeuchi Takeuchi Takeuchi1, 2, Y. TogashiTogashi Togashi 1, 2, Y. Kamihara Kamihara Kamihara 3, T. Fukuyama 3, H. YoshiokaYoshioka YoshiokaYoshioka4, A. Inoue 5, H. Katsuki Katsuki KatsukiKatsuki3, K. Kiura Kiura 6, K. Nakagawa Nakagawa7, T. Seto 8, M. Maemondo MaemondoMaemondo 9, T. Hida Hida 10 , M. Harada Harada 11 , Y. Ohe 12 , N. Nogami 13, N. YamamotoYamamoto Yamamoto 14 , M. Nishio 15, T. TamuraTamura 16

 

Annals of Oncology Advance Access published October 20, 2015

Lire la suite

Article du mois d’Octobre

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

H. Borghaei, L. Paz‑Ares, L. Horn, D.R. Spigel, M. Steins, N.E. Ready, L.Q. Chow,
E.E. Vokes, E. Felip, E. Holgado, F. Barlesi, M. Kohlhäufl, O. Arrieta, M.A. Burgio,
J. Fayette, H. Lena, E. Poddubskaya, D.E. Gerber, S.N. Gettinger, C.M. Rudin,
N. Rizvi, L. Crinò, G.R. Blumenschein, Jr., S.J. Antonia, C. Dorange,
C.T. Harbison, F. Graf
Finckenstein, and J.R. Brahmer
New England Journal of Medicine (Impact Factor: 55.87). 09/2015

Lire la suite

Article du mois de Juin

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Julie Brahmer, M.D., Karen L. Reckamp, M.D., Paul Baas, M.D., Lucio Crinò, M.D., Wilfried E.E. Eberhardt, M.D., Elena Poddubskaya, M.D., Scott Antonia, M.D., Ph.D., Adam Pluzanski, M.D., Ph.D., Everett E. Vokes, M.D., Esther Holgado, M.D., Ph.D., David Waterhouse, M.D., Neal Ready, M.D., Justin Gainor, M.D., Osvaldo Arén Frontera, M.D., Libor Havel, M.D., Martin Steins, M.D., Marina C. Garassino, M.D., Joachim G. Aerts, M.D., Manuel Domine, M.D., Luis Paz-Ares, M.D., Martin Reck, M.D., Christine Baudelet, Ph.D., Christopher T. Harbison, Ph.D., Brian Lestini, M.D., Ph.D., and David R. Spigel, M.D.

May 31, 2015DOI: 10.1056/NEJMoa1504627

Lire la suite